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Abstract 
Objective: To investigate whether hip shape contributes to osteoarthritis (OA) development, 
we investigated relationships between known OA susceptibility loci and hip shape in a 
population-based cohort of peri-menopausal women. 
Methods: Hip shape was measured using Statistical Shape Modelling, on hip DXA scans from 
mothers in the Avon Longitudinal Study of Parents and Children (ALSPAC). The proximal 
femur and superior acetabulum were outlined, and independent hip shape modes generated. In 
a sub-regional model, points were restricted to the acetabulum and superior femoral head. 
Associations between 10 OA-related SNPs, identified by literature search, and shape modes 
were analysed in a multivariate canonical correlation analysis.  
Results: 3,111 females had genetic and hip shape data (mean 48 years). The KLHDC5-PTHLH 
rs10492367 OA risk allele was associated with a wider upper femur in the whole shape model 
(P=1x10-5). The DOT1L rs12982744 OA risk allele was associated with reduced superior joint 
space in the sub-regional shape model (P=2x10-3). COL11A1 rs4907986 OA risk allele was 
associated with lateral displacement of the femoral head relative to the acetabulum in the sub-
regional shape model (P=5x10-4). Regional association plots identified an additional COL11A1 
locus in moderate LD with rs4907986, which was more strongly associated with hip shape 
(rs10047217, P=6x10-6). Co-localisation analysis indicated sharing of genetic signals for hip 
shape and hip OA for the KLHDC5-PTHLH and COL11A1 loci. 
Conclusion: Hip OA susceptibility loci were associated with shape in this study suggesting that 
these loci (and potentially yet to identified hip OA loci) could contribute to hip OA in later life 
via perturbing biologic pathways that mediate morphology development.  
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Introduction 
Genetic association studies have identified several susceptibility loci for hip osteoarthritis 
(OA), which may ultimately improve understanding of pathogenesis and lead to the 
development of new treatments (1). Whereas initial studies were based on case collections, 
defined by radiographic hip osteoarthritis (RHOA) or history of joint replacement, availability 
of more precise endophenotypes may increase the chances of genetic discovery, as suggested 
for hypertrophic OA and superior joint space narrowing (2). There is also considerable interest 
in the role of shape abnormalities in hip OA, exemplified by cam-type deformities, caused by 
extra bone growth around the anterolateral aspect of the femoral head leading to femoro-
acetabular impingement (FAI) (3), which are associated with premature onset of OA (4, 5). In 
the Rotterdam study, individuals with cam deformity and acetabular dysplasia were reported 
to have around a 2 fold increased risk of radiographic hip OA compared to controls (6).    
Rather than investigating specific geometric/anatomical measures, statistical shape modelling 
(SSM) can be employed, whereby Principal Component Analysis (PCA) is used to derive a set 
of orthogonal hip shape modes (HSMs), which together provide a more complete description 
of hip shape (7). Several SNPs have been associated with changes in hip shape using SSMs. 
An intronic DIO2 SNP was associated with the first HSM in a small study comprising of 190 
sib pairs and two trios of Dutch ancestry, using a model built on the medial femur, acetabulum 
and pelvis (8). Two independent missense FRZB SNPs were associated with the second HSM 
in a nested case control study of older women from the study of osteoporotic fractures 
(n=1,046) using a superior femur model (9). An intronic SNPs within ASTN2 and a 3 prime 
UTR SNP within GLT8D1 were associated with distinct HSMs in 929 subjects with unilateral 
hip OA, in a model built on the superior femur from the unaffected hip. In the same study, a 
SNP located near IFRD1 was also associated with a combination of three distinct modes in a 
multivariate canonical correlation analysis (10).   
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The above studies were based on older participants with established hip OA, making it difficult 
to distinguish genetic associations with hip shape representing part of the OA phenotype, from 
shape changes predisposing to subsequent OA development. To investigate the latter, genetic 
associations with hip shape need to be examined in younger people from the general 
population. Such analyses, however, are difficult to undertake since hip radiographs are 
generally avoided in asymptomatic younger individuals due to their relatively high radiation 
dose. An alternative approach is to use DXA-based measures, which are associated with 
considerably lower radiation exposure, and are available in several large population-based 
cohorts. For example, HSMs derived from hip DXA scans, based on an 85 point model 
comprising the femoral head, acetabulum and femoral neck were recently reported to be 
associated with radiographic OA in the Tasmanian Older Adult Cohort (11).  
To establish whether genetic risk factors for hip OA partly act through alterations in shape, we 
examined associations between established hip OA susceptibility loci, and DXA-derived hip 
shape, in a population-based cohort of peri-menopausal women. Rather than performing a 
series of univariate tests on each of the hip shape modes, in order to model the effects of HSMs 
together we applied the multivariate canonical correlation approach (CCA) described by 
Lindner et al (10). In addition, we investigated the use of sub-regional HSMs, intended to focus 
on shape abnormalities involved in the development of hip OA.  
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Materials and Methods 
Hip OA Candidate Genes The literature was examined to find studies which associated single 
nucleotide polymorphisms (SNPs) with hip OA. The keywords Osteoarthritis AND genome 
were initially searched for in Pubmed and the publications returned from this search were 
manually reviewed. Genetic associations with hip OA and overall OA (as indicated by total 
joint replacement) were considered only (i.e. associations with other OA site, for example, knee 
or hand OA were excluded).  A significance threshold of P< 5x10-8 was used to identify 
associations from GWASs, and a significance threshold of P < 5x10-5 was applied to candidate 
gene studies. Since the present investigation was based on a female-only cohort, genetic 
associations reaching the threshold in males only (i.e. not in combined genders and females) 
were excluded.       
 
Study participants 
The study was based on mothers from the Avon Longitudinal Study of Parents and Children 
(ALSPAC) cohort, a longitudinal birth cohort that recruited pregnant women resident in a 
geographical area in the South West of England, UK, with an expected delivery date between 
April 1, 1991, and December 31, 1992. The present study uses data from follow-up research 
clinics of mothers between 2008 and 2011 (12, 13). All eligible mothers (i.e. still engaged with 
the study; alive with known contact details and who had not withdrawn their consent) were 
invited to these assessments. Of 11,264 (82%) women invited, 4,834 (43%) attended. Informed 
consent was collected for all in line with the Declaration of Helsinki (14). Ethical approval for 
the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research 
Ethics Committees (North Somerset & South Bristol Research Ethics Committee: 
08/H0106/96). The study website contains details of all the data that is available through a fully 
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searchable data dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/data-
dictionary/). 
 
DXA protocol 
Hip dual-energy X-ray absorptiometry (DXA) scans, performed by GE Lunar Prodigy Scanner 
(Madison, WI, USA), were acquired and analysed according to manufacturer’s standard 
scanning and positioning protocol. At the same visit, height was measured to the nearest 0.1 
cm using a Harpenden Stadiometer (Holtain Ltd. Crymych, UK) without shoes, and weight to 
the nearest 50 g using Tanita weighing scales (Tanita UK Ltd, Uxbridge). 
 
Statistical shape modelling 
Hip DXA scans were uploaded to the SHAPE software (University of Aberdeen) to conduct 
the SSM. SHAPE automatically placed points around anatomical landmarks of the upper femur 
and adjacent acetabulum according to a pre-defined 53 point template (see Figure 1). 
Repeatability was evaluated by comparing two experienced operators on a sample of 100 hips 
from ALSPAC kids (age 18).  Results showed high consistency between both operators with 
the mean difference (across all 53 points on the template) being 1.8 pixels (SD=0.4, range = 
1.0 to 2.9).  All operators were trained on a separate set of n100 hips prior to the main analysis 
to ensure the same high standard of placement was maintained.  Hip shape size and rotation 
were standardized by Procrustes analysis, and Principal Component Analysis (PCA) performed 
to produce a set of HSMs describing linearly independent variations in shape present within 
the entire sample (15, 16). To aid comparison with other studies, we used HSMs previously 
generated in ALSPAC from a larger PCA combining scans from multiple cohorts, for the 
purposes of performing a GWAS meta-analysis (17). The mode scores follow a standard 
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Normal distribution and describe SD changes from the mean shape. As a quality control 
measure, outliers (mode scores above or below 4SDs, n=48) were manually checked by two 
operators, and point placement corrected where necessary to ensure points were positioned 
accurately on the bone edge. The first ten modes, accounting for 85% of total variance, were 
taken forward for genetic association studies (see supplementary Figure 1). Three further sub-
regional models were built, based on a subset of points, of which the first five modes 
(explaining > 85% variability within each sub-model) were used for genetic association 
analyses: femoral head (supplementary Figure 2), cam-type deformity (supplementary Figure 
3) and superior joint space (supplementary Figure 4).   
Genotypic data 
Genome-wide SNP data available on the ALSPAC Mother (n=10,015) samples were used for 
this study. SNPs with a genotype missingness rate greater than 5%, extreme deviation from 
Hardy-Weinberg equilibrium (P < 5x10-7), and a minor allele frequency (MAF) of less than 
1% were removed. Individuals with greater than 5% missingness, extreme heterozygosity, 
evidence of population stratification and cryptic relatedness (IBD > 0.125) were excluded.  
Details of this pipeline are reported elsewhere (18). Genotypic data were phased using ShapeIT 
version 2 and imputed on IMPUTE version 2.2.2 using the Haplotype Reference Consortium 
(HRC) version 1 panel. SNPs with an imputation info score of less than 0.8 and MAF < 0.01 
were subsequently removed, and genotypes were derived from the imputed data using GTOOL 
and a hard genotype call threshold of 0.9. The genotypes of all the candidate OA SNPs 
identified were then extracted for the association analysis. The surrounding genomic region 
was also extracted in order to generate the regional association plots and conduct the 
colocalization analysis. 
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Statistical analysis 
Canonical Correlation Analysis (CCA) was used to simultaneously test for association between 
a given SNP and multiple shape modes, using the canon command in Stata version 13.1, which 
assumes an allele dose genetic model. The first ten ancestry principal components and age were 
regressed on each of the HSMs to obtain residual scores, which were then used in the CCA 
models. As a sensitivity analysis, SNP associations were also pre-adjusted for height before 
conducting the CCA.  A linear combination of the first ten HSMs for the whole shape model 
and the first five modes in the sub-regional models were tested in the CCA. To visualize shape 
effects, plots showing the deviation from the mean shape according to the risk allele for hip 
OA, based on the significant modes identified from CCA, were generated in SHAPE. Where 
CCA revealed evidence of associations with multiple modes, the canonical weightings of the 
different modes were used to plot the composite shape change observed for the SNP. A 
Bonferroni-adjusted -p-value was applied of P<1.25x10-3, to account for the multiple SNPs 
tested.  To conduct conditional analysis on the multiple SNP signals detected within COL11A1, 
a MANOVA regression framework was employed in Stata using the mvreg command.  
Approximate Bayesian co-localization analysis was carried to determine the probability of hip 
shape and hip OA traits sharing the same casual SNP within the genomic regions identified.  
This method calculates a posterior probability for five separate hypotheses: H0: SNP is 
associated with neither trait, H1: SNP is associated with hip shape only, H2: SNP is associated 
with hip OA only, H3: both traits are associated but with independent causal SNPs and H4: both 
traits are associated with the same causal SNP.  High posterior probability for H4 in comparison 
to the other four hypotheses is evidence for colocalization of genetic signal. The coloc.abf 
function in the coloc package in R was used (19-21). Three prior probabilities were required to 
be set:  the expected proportion of SNPs associated with hip shape (p1), with hip OA (p2) and 
with both these traits (p12). The default priors used in the coloc program was used which were 
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p1=1x10
-4, p2 = 1x10
-4 and p12 = 1x10
-6 CCA p-values and MAF obtained from this study were 
used as the input for the hip shape associations and p-values and MAF from the arcOGEN 
GWAS (discovery cohort) (22) were used for the hip OA associations.   
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Results 
OA Candidate genes 
10 SNPs were selected from the literature as having evidence for association with hip OA 
(Table 1). In the majority of the studies, OA cases comprised of RHOA, severe symptomatic 
hip OA, total hip replacement (THR), or a combination. A single candidate SNP as well as a 
neighbouring SNP was also found to be associated with hip shape by SSM studies based on 
radiographs (see Table 1 legend). 
 
Associations between OA candidate genes and hip shape 
3,111 ALSPAC mothers had valid genetic and DXA hip shape data. At the time of DXA scans 
these women were mean age 48 years (range 34-61 years),  2,191 (70.4%) women were pre-
menopausal and 920 (29.6%) 920 (29.6%) post-menopausal. All hip shape modes were 
Normally distributed. Results of genetic association analysis based on the hip shape models are 
shown in Table 2. KLHDC5-PTHLH rs10492367 SNP showed a Bonferroni significant 
association (ρ (canonical correlation coefficient) = 0.11; P=1x10-5), whereas weaker evidence 
of association (nominal significance, P<0.05) was observed for COL11A1 rs4907986. For the 
superior joint space model, a Bonferroni significant association was observed for COL11A1 
rs4907986 (ρ=0.085; P=5x10-4), and a suggestive association for DOT1L rs12982744 
(ρ=0.077; P=2x10-3) which was on the borderline of Bonferroni significance, whereas 
KLHDC5-PTHLH rs10492367 (P=0.02) showed weaker evidence of association (Table 2). 
Only relatively weak evidence of associations (P<0.05) were observed for the femoral head 
shape model (KLHDC5-PTHLH rs1049236 and COL11A1 rs4907986), no nominally 
significant associations were observed for the cam-type deformity model (Table 2). None of 
the associations investigated attenuated after additional adjustment for height (Supplementary 
table 1). 
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KLHDC5-PTHLH rs10492367 
The relationship between KLHDC5-PTHLH rs10492367 and whole hip shape was 
predominantly explained by a positive association with mode 1, indicating greater width to 
height ratio. A positive association with mode 10 was also detected by CCA (Supplementary 
table 2). Subsequently, weightings (x2 to magnify effects for illustration) from CCA were 
entered into SHAPE. Modelling both modes together using CCA indicated that the KLHDC5-
PTHLH rs10492367 risk allele is associated with a relatively wide and short upper femur 
(Figure 2A). Regional association plot for the genetic association with whole hip shape from 
the multivariate analysis showed similar associations for several neighbouring SNPs in high 
linkage disequilibrium (LD) with rs10492367 (Figure 2B). Further regional association plots 
comparing hip shape associations from this study with hip OA associations from arcoGEN (22) 
revealed a similar association pattern for each phenotype.  Co-localization analysis confirmed 
that both these traits shared a single causal SNP (Posterior Probability (PP ) = 99%). 
 
DOT1L rs12982744  
The relationship between DOT1L rs12982744 and shape in superior joint space model was 
primarily explained by a positive association with mode five, indicating reduced joint space. A 
positive association with mode 1 also contributed to this relationship, indicating medial 
displacement of the femoral head relative to the acetabulum (Supplementary table 3). 
Modelling both modes simultaneously using CCA suggested that the DOT1L rs12982744 risk 
allele is associated with reduced supero-lateral joint space (Figure 3A). In the regional 
association plot, several neighbouring SNPs in moderately high LD with DOT1L rs12982744 
showed equivalent shape associations (Figure 3B). Further regional association plots 
comparing shape associations with hip OA associations from arcOGEN (22) suggested these 
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signals may overlap (inference from formal colocalization analysis was limited by the 
relatively weak associations of this locus with hip shape and hip OA).  
 
COL11A1 rs4907986 
The relationships between the rs4907986 locus and shape in the superior joint space model was 
largely explained by an inverse association with mode 1, reflecting lateral displacement of the 
femoral head relative to the acetabulum. In addition, an inverse association was observed with 
mode 5, indicating wider joint space (Supplementary table 3). Modelling both these modes 
simultaneously using CCA suggested that the risk allele is associated with lateral displacement 
of the femoral head combined with widening of the supero-lateral joint space (Figure 4A). 
Regional association plots of this multivariate association showed a substantial number of 
signals in moderately strong linkage across the COL11A1 gene. An additional association with 
superior joint space shape of a similar strength was detected with rs2615977 (P=0.00048), 
which was previously identified as associated with hip OA in the stage one arcOGEN GWAS 
(OR = 1.10, P=1.10x10-5 combined discovery and replication) (23).  rs2615977 and rs4907986 
occurred in two distinct LD blocks and were in moderate LD with each other (r2 = 0.353) 
(Figure 4B).  A further SNP (rs10047217) was identified which had a stronger association with 
shape (P=3x10-6) than either of these two SNPs; after conditioning on rs10047217 there was 
no evidence that either rs2615977 or rs4907986 were independently associated with shape 
(P=0.68 and P=0.13 respectively). Regional association plots comparing shape associations 
with hip OA associations from arcOGEN (22) indicated sharing of association signals between 
each of the traits. Co-localization analysis suggested that both these traits shared a single causal 
SNP (PP= 70%). 
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Discussion 
We found that several known OA susceptibility SNPs are associated with hip shape in whole 
and/or sub-regional hip models, in a cohort of peri menopausal women. Specifically, KLHDC5-
PTHLH rs10492367 was associated with a wider upper femur, DOTL1 rs12982744 with 
reduced supero-lateral joint space, and COL11A1 rs2615977 and rs4907986 with lateral 
displacement of the femoral head relative to the acetabulum. Several shape differences have 
previously been reported to be associated with OA, but it is often difficult to distinguish 
changes causing OA from those secondary to it. By studying individuals at an age when they 
are likely to be disease free, indices of hip shape are likely to represent causal pathways in OA 
development as opposed to changes consequent to OA.  Co-localisation analysis supported the 
conclusion of single causal variants giving rise to both hip shape and OA associations (rather 
than the pattern being driven by horizontal pleiotropy as a result of linkage disequilibrium) for 
the KLHDC5-PTHLH and COL11A1 loci. However, our analysis could not rule out alternative 
mechanisms of pleiotropy and so are not confirmative of a causal mechanism. 
 
KLHDC5-PTHLH rs10492367 had previously been found to be associated with hip OA 
following a GWAS with replication in the arcOGEN case control study (22). This locus is 
downstream to the gene encoding parathyroid hormone-related protein (PTHrp), an important 
regulator of endochondral bone development (24). Conceivably, the difference in height to 
width ratio associated with KLHDC5-PTHLH rs10492367 is a consequence of altered 
endochondral bone development. However, it is unclear how this shape change might cause 
hip OA. Previous DXA-based studies have reported associations between altered femoral 
geometry and risk of subsequent hip OA, exemplified by a report that wider femoral neck and 
medial displacement of the centroid position are risk factors for incident radiographic hip OA 
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(25). However, we are not aware of any previous studies that directly related height to width 
ratio of the upper femur to risk of hip OA.  
 
DOT1L rs12982744, which we found to be associated with supero-lateral joint space, was 
previously reported to be associated with hip OA in a look-up of the TREAT-OA consortium 
(26). This SNP had previously been identified from a GWAS of joint space width, assessed 
using hip radiographs from older individuals (predominantly in their mid-sixties) from 
population based cohorts (27). This apparent effect on cartilage integrity is consistent with 
observations that DOT-1-like histone H3 methyltransferase, which is encoded by DOT1L, 
influences chondrogenesis (27). That DOT1L rs12982744 is also associated with joint space in 
individuals in their late forties as studied here, suggests DOT1L variation affects joint space 
prior to the onset of symptomatic OA, consistent with a role in OA pathogenesis. As well as 
joint space narrowing, simultaneous modelling of both modes related to DOT1L rs12982744 
suggested that the OA risk allele causes a progressive reduction in joint space laterally (see 
Figure 2). This appearance is somewhat reminiscent of FAI, and raises the possibility that bony 
changes also contribute to the increased hip OA risk associated with DOT1L rs12982744. 
 
Of the two independent COL11A1 candidate SNPs examined, rs4907986, which had previously 
been associated with hip OA in a meta-analysis of OA candidate genes (28), showed the 
strongest evidence for association in the superior joint space narrowing model.  However, 
further analysis on the COL11A1 region did reveal that an alternative SNP (rs10047217), which 
was in moderate LD with rs4907986, had a stronger association with hip shape, suggesting that 
this SNP could be the causal SNP. COL11A1 encodes COL11A1, a fibrillary protein within 
cartilage, mutations of which are known to cause severe osteoarthritis secondary to spondylo-
epiphyseal dysplasia as in Stickler’s syndrome (29). Our observation that COL11A1 risk alleles 
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are associated with lateral displacement of the femoral head relative to the acetabulum is 
reminiscent of acetabular dysplasia. The latter is associated with a reduction in acetabular 
coverage of the femoral head which is thought to increase hip OA risk through increased 
contact stress arising from the smaller weight-bearing surfaces. Acetabular coverage can be 
quantified on hip radiographs through measurement of lateral centre-edge angle, a reduction of 
which has been associated with increased risk of incident hip OA (30, 31) and has also been 
associated with an increased risk of total hip replacement, independently of radiographic OA 
(32).  
 
There was some overlap in findings across different models. For example, KLHDC5-PTHLH 
rs10492367 showed weak associations in femoral head and acetabular models, and DOT1L 
rs12982744 and COL11A1 rs4907986 weak association in the whole shape model, which is to 
be expected given the overlap in points between models. However, that DOT1L and COL11A1 
SNPs showed considerably stronger associations in the acetabular model suggests the use of 
sub-regional models is helpful in detecting genetic associations with hip shape, presumably 
reflecting the localised nature of underlying biological processes. Whereas several other 
genetic susceptibility SNPs for hip OA have previously been reported in association with SSM-
derived hip shape (10, 33, 34), we did not find these to be related to DXA-derived hip shape. A 
possible explanation for this is that the latter studies were based on hip OA cases, which may 
have resulted in the detection of SNPs associated with features related to established OA, as 
opposed to factors involved in initial pathogenesis. 
 
Strengths and limitations 
To our knowledge, this is the first study to describe genetic associations with DXA-derived hip 
shape. A further strength is our use of sub-regional models, which enhanced discovery of 
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genetic associations. Although the modes in the sub-regional models will be partly correlated 
with certain modes in the whole shape model, as the sub-regional models describe a more 
precise phenotype they will be better powered to detect SNPs associated with pathways that 
mediate localised changes to hip morphology. Another strength was the relatively young 
population based cohort, enabling us to identify genetic associations with features related to 
OA development rather than established OA, made possible by our use of DXA images which 
are more widely available in population-based cohorts compared with radiographs. One of the 
main limitations is that the present study was restricted to females, and it is unclear whether 
equivalent associations exist in males. The relatively low resolution of DXA compared with 
radiographs represents a significant disadvantage in detecting shape changes, not the least due 
to the difficulty of detecting and excluding artefacts such as osteophytes. However, the 
consistency of our findings for DOT1L rs12982744, which was associated with joint space 
narrowing both in our study and a previous radiographic study albeit in older individuals (27), 
supports the fact that DXA-derived hip shape provides sufficient accuracy for genetic 
association studies.  In addition, although we have interpreted certain hip shape modes in terms 
of specific shape alterations, since each mode encompasses multiple shape changes, it is 
difficult to be certain of which component is relevant for pathology.  Therefore, although our 
results suggested genetic associations with features such as FAI and acetabular un-coverage, 
this requires confirmation by relating SSM-derived shape to measures such as lateral centre-
edge angle used to define these abnormalities on radiographs.  
 
Conclusions 
Having examined 10 SNPs previously reported to be associated with risk of hip OA, three 
SNPs (in three loci) were found to be associated with DXA-derived hip shape, one in the whole 
shape model, and two in a novel sub-regional model restricted to the upper femoral head and 
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acetabulum. Shape changes found to be related to OA risk alleles in the sub-regional model 
were reminiscent of FAI and acetabular dysplasia, which have previously been implicated in 
OA pathogenesis. In contrast, in the whole shape model, the OA risk allele was related to upper 
femur width to height ratio, pointing to a potentially novel disease mechanism. The more 
precise understanding of hip OA pathogenesis gained through studying SSM endophenotypes 
may enable improved targeting of functional studies leading to better understanding of 
molecular mechanisms and potential improved resolution to determine causal SNPs from 
GWASs. Our findings need replication, but they suggest that hip shape may be a marker of 
future OA risk and could potentially provide a means of early identification and prevention.  
As hip OA is a complex phenotype, loci are likely to be associated with different pathways to 
the disease.  We infer that the hip OA SNPs identified in this hip shape study will, at least in 
part, act through impacting molecular pathways which mediate femur morphology 
development.   
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Figure Legends 
Figure 1 
Points used in different hip shape models.  Hip shape template annotated with the points 
included in the (a) whole shape model (points 0,1,44, 45, and 57 (marked with x) were 
excluded from the final model due to inconsistency of point placement); (b) superior 
acetabular model, comprising points 18 to 23 on the femur, and points 56 to 51 on the 
acetabulum; (c) femoral head model, comprising points 9 to 23 on the femoral head; and (d) 
the cam-type deformity model, comprising points 21 to 29 on the femoral head and neck. Key 
points, representing anatomical reference points, are shown in red. 
Figure 2 
(A) Effect of the rs10492367 KLHDC5-PTHLH locus on whole hip shape, modelled according 
to the hip OA risk allele (T allele), using loadings from CCA correlation. Canonical function 
coefficients (x2) were entered into SHAPE, for those modes showing significant associations 
(see Supplementary Table 3). Mean shape (solid line), composite shape change observed 
(dotted line). (B) Regional association plot showing the multivariate associations (-log10 P-
value) for the whole hip model for SNPs surrounding KLHDC5-PTHLH rs104292367 locus 
(annotated as purple diamond).  SNP associations are coloured according to strength of LD 
with rs104292367.   
Figure 3 
(A) Effect of the rs12982744 DOT1L locus on hip shape in the acetabular model, modelled 
according to hip OA risk allele (C allele), using loadings from CCA correlation. Canonical 
function coefficients (x2) were entered into SHAPE, for those modes showing significant 
associations (see Supplementary Table 4). Mean shape (solid line), composite shape change 
observed (dotted line). (B) Regional association plot showing the multivariate associations for 
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the acetabular model for SNPs within DOT1L.  SNP associations are coloured according to 
strength of LD with the index SNP (rs12982744, purple diamond).   
Figure 4 
(A) Effects of rs4907986 COL11A1 locus on hip shape in the acetabular model, modelled 
according to the hip OA risk allele (rs4907986: T allele), using loadings from CCA correlation. 
Canonical function coefficients (x2) were entered into SHAPE, for those modes showing 
significant associations (see Supplementary Table 4). Mean shape (solid line), composite shape 
change observed (dotted line). (B) Regional association plot showing the multivariate 
associations for the acetabular model for SNPs within COL11A1.  SNP associations are 
coloured according to LD with the index SNP (rs4907986, purple diamond).  Rs2615977 SNP 
which was also associated with hip OA in another study and the rs2615977 which was the top 
hit for hip shape in this study are also highlighted with arrows in the plot.  
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Table 1 Hip OA candidate SNPs selected in this study from (a) GWASs (b) candidate gene studies.   
 Study type SNP EA NON EA gene phenotypic association OR P Reference 
GWAS  
rs69761 T C GLT8D1 TJR 1.12 7.24x10-11 (22) 
rs48367322 C T ASTN2 THR (females) 1.2 6.11x10-10 (22) 
rs6094710 A G NCOA3 RHOA 1.28 7.90x10-9 (35) 
rs10492367 T G KLHDC5-PTHLH RHOA/THR 1.14 1.48x10-8 (22) 
rs835487 G A CHST11 THR 1.13 1.64x10-8 (22) 
rs11842874 G A MCF2L ROA/TJR 0.85 2.1x10-8 (36) 
Candidate Gene  
rs143383 C T GDF5 RHOA (Asians) 1.79 1.8x10-13 (37) 
rs12982744 G C DOT1L THR/RHOA 0.91 8.1x10-8 (35) 
rs4907986 C T COL11A1 RHOA/THR 0.89 1.29x10-5 (38) 
rs1241164 T C COL11A1 RHOA/THR 0.82 1.47x10-5 (38) 
 rs2862851 T C TGFA RHOA/THR 0.059 4.3x10-5 (27) 
 
The final combined statistic from aggregating the effects across all cohorts involved in the meta-analysis is reported (for all studies except rs143383 
where a meta-analysis was not conducted).  Significance threshold to include SNPs from GWASs was P<5x10-8 and from candidate gene studies 
was P < 5x10-5. OA phenotypes comprised RHOA (radiographic hip OA), JSN (joint space narrowing), TJR (total joint replacement) and THR 
(total hip replacement). EA allele coded as the minor allele in the sample. Pairwise r2 between rs4907986 and rs1241164 = 0.081. 
 
Table 2 Multivariate associations for the hip OA candidate gene loci across the whole hip and different sub-regional shape models. 
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  whole hip  superior JSN  femoral head  cam-type deformity 
SNP locus ρ P  ρ P  ρ P  ρ P 
rs10492367 KLHDC5-PTHLH 0.11 0.000014  0.064 0.024*  0.064 0.024*  0.024 0.87 
rs4907986 COL11A1 0.078 0.046*  0.085 0.00049  0.061 0.044*  0.037 0.51 
rs12982744 DOT1L 0.074 0.07  0.077 0.0024*  0.05 0.17  0.043 0.34 
rs6094710 NCOA3 0.074 0.078  0.038 0.5  0.016 0.98  0.053 0.12 
rs143383 GDF5 0.072 0.11  0.04 0.45  0.036 0.57  0.027 0.81 
rs4836732 ASTN2 0.068 0.15  0.053 0.12  0.019 0.95  0.032 0.68 
rs6976 GLT8D1 0.053 0.57  0.042 0.36  0.039 0.44  0.019 0.96 
rs835487 CHST11 0.052 0.59  0.049 0.18  0.042 0.35  0.042 0.36 
rs11842874 MCF2L 0.05 0.64  0.032 0.66  0.043 0.34  0.029 0.76 
rs1241164 COL11A1 0.049 0.68  0.052 0.13  0.02 0.93  0.032 0.69 
rs2862851 TGFA 0.049 0.70  0.048 0.22  0.017 0.97  0.033 0.65 
 
Canonical correlation (ρ) between genotype and hip shape in multivariate analysis. A Bonferroni corrected threshold of P < 0.00125 was used to 
identify associations (marked in bold); associations reaching nominal significance (P < 0.05) are starred.   
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